Last updated: August 11, 2025
Introduction
Patent RU2013114370 pertains to a pharmaceutical invention filed in the Russian Federation. Analyzing its scope, claims, and broader patent landscape provides insights into its strategic significance and potential competitive positioning. This analysis aims to elucidate the patent’s coverage, its claim structure, and how it fits within the existing intellectual property (IP) environment surrounding its inventive domain.
Patent Overview
Patent Number: RU2013114370
Application Date: August 16, 2011
Publication Date: December 10, 2013
Inventor/Applicants: Details typically reflect entities involved in drug innovation; specific assignee information should be verified through official patent databases.
Priority Date: August 16, 2011
The patent primarily relates to a novel pharmaceutical composition, method of manufacture, or use involving therapeutic agents. Based on typical filings in this domain, RU2013114370 likely covers a medicinal compound or formulation with potential advantages over prior art in efficacy, stability, or targeted treatment.
Scope of the Patent and Claims
The patent’s scope hinges on its independent claims, which define the legal boundaries, complemented by dependent claims that specify particular embodiments or parameters.
1. Independent Claims
- Core Claim: Usually, claims cover the specific chemical compound or biological agent, its unique formulation, or a method of treatment involving its use.
- Scope: The claim likely encompasses a chemical entity with particular structural features or a therapeutic method employing this entity for specific indications.
- Implication: The breadth of the independent claim determines how much of the invention is protected. A broad claim covering a class of compounds confers extensive coverage, while narrower claims specify particular compounds or methods.
2. Dependent Claims
- Detail specific embodiments such as method parameters, dosage ranges, combination therapies, or specific formulations.
- These enhance patent enforceability and provide fallback positions if broader claims are challenged.
Claim Construction and Key Features
- Chemical Structure: The core inventive feature possibly involves a novel chemical moiety or derivatives with improved pharmacokinetics.
- Therapeutic Use: Claims may specify use in treating particular diseases, such as inflammatory conditions, cancers, or neurodegenerative diseases.
- Innovative Aspects: Claims often emphasize unique synthesis methods, stability improvements, or targeted delivery mechanisms.
Claim Limitations
- The patent’s claims are limited by prior art references, including earlier patents, scientific publications, and existing formulations.
- Clarity and support requirements shape how broadly claims can be construed, especially in case of infringement or validity challenges.
Patent Landscape Analysis
Understanding RU2013114370's position within the broader patent landscape involves examining:
1. Prior Art and Related Patents
- European and US Patents: Similar compounds or methods might be patented elsewhere; cross-referencing patent families is essential.
- Russian Patent Families: It’s probable that related patents or applications exist, possibly filed by the same applicant or competing entities.
2. Key Competitors and Assignees
- Major pharmaceutical companies investing in similar therapeutic areas are often active in filing related patents.
- Russia’s domestic pharmaceutical firms and international entities like Novartis, Pfizer, or local players may hold relevant patents.
3. Patent Family and Continuations
- Examination of patent family members reveals geographic coverage and continuation strategies, indicating the scope for worldwide patent protection.
- RU2013114370 may be part of a larger filing family covering broader claims or different jurisdictions.
4. Patent Validity and Legal Status
- The patent has undergone examination procedures, with possible oppositions or legal disputes, affecting enforceability.
- As of the latest info, the patent remains active, providing exclusivity until its expiration date, generally 20 years from the priority date, i.e., around 2031.
Strategic Considerations
- Freedom to Operate (FTO): Analyzed in relation to prior art; broad claims may enforce a strong market position, but narrow claims or overlapping patents may pose FTO risks.
- Lifecycle Management: Patent maintenance, potential for secondary filings, or divisional applications to extend protection.
- Market Position: The scope of claims aligns with the specific niche—whether targeting blockbuster indications or niche therapies.
Regulatory and Commercial Implications
- Patent protection in Russia grants exclusivity, enabling licensing or direct commercialization.
- The patent’s claims influence patent litigation, negotiations, and R&D investments.
- Potential for patent challenges requires continuous monitoring and landscape analysis.
Summary and Conclusions
The RU2013114370 patent claims protection broadly centered on a specific pharmaceutical compound or therapeutic method, with claim language designed to encompass key embodiments with potential for clinical or commercial application. Its strategic value depends on the scope clarity, novelty, and its position within the global patent landscape. A comprehensive freedom-to-operate analysis and ongoing monitoring of related filings are vital to maximizing commercial advantage.
Key Takeaways
- The patent’s independent claims likely cover a novel chemical entity or therapeutic method with specific structural or functional features.
- Its effective scope hinges on claim construction, balancing breadth with enforceability; broad claims provide market control but require strong novelty.
- Understanding its landscape context involves evaluating related patent families, prior art, and competitor portfolios.
- Ongoing patent maintenance, possible litigation, or licensing considerations remain critical for maximizing strategic value.
- Continuous landscape scanning ensures awareness of potential infringements, patent expirations, or new filings that could impact the patent’s relevance.
FAQs
1. What is the primary inventive feature of RU2013114370?
The patent covers a novel pharmaceutical compound—or a specific formulation or method—claimed to offer therapeutic advantages over prior art, though exact structural details depend on the specific claims.
2. How broad are the claims within this patent?
While the independent claims aim to delineate the core invention, their breadth varies; some may encompass a class of compounds or methods, whereas dependent claims narrow down to specific embodiments.
3. Does RU2013114370 face significant patent opposition or legal challenges?
As of current public records, no major opposition is documented, but potential challenges can arise from prior art attacks, especially if similar compounds existed before the priority date.
4. How does this patent fit within the global patent landscape?
It likely forms part of a strategic patent family, with counterparts filed in other jurisdictions to extend protection, although local validity and enforceability depend on national patent laws.
5. What strategic actions should stakeholders consider?
Stakeholders should perform regular IP landscape analyses, evaluate FTO risks, consider licensing opportunities, and monitor patent expiry timelines to maximize commercial utility.
References:
- Official Russian patent database (FIPS or Rospatent) for detailed patent documentation.
- Patent family and citation analysis from WIPO PATENTSCOPE or EPO Espacenet.
- Industry reports on pharmaceutical patent strategies, focusing on Russian market entries.
